Skip to content
GLP-1 Scorecard
Menu
Graded #209

Eve

Eve is a women's-health-focused GLP-1 telehealth platform — distinctive positioning in a largely gender-neutral market — offering both compounded semaglutide and tirzepatide (including an oral sublingual form) and brand-name Ozempic, Wegovy, and Mounjaro on one account.

Visit Eve ↗We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$195/mo (compounded)
Tirzepatide
$195/mo (compounded)
Coverage
Coverage not published
Brand-name
Yes

Weigh Eve against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value55/100
Dose & formulation88/100
Clinical oversight79/100
Labs & monitoring52/100
Fulfillment67/100
Contract terms41/100

Strengths

  • Genuinely women's-health-focused — fills a real gap among gender-neutral GLP-1 competitors
  • Both compounded and brand-name FDA-approved options (Wegovy/Ozempic/Mounjaro) on one platform — rare
  • Publishes the FDA compounded-medication disclaimer
  • Oral sublingual semaglutide offered alongside injectable

Where it loses points

  • Full states-served list not disclosed publicly
  • 503A pharmacy partner not named, and 503A vs 503B status not specified
  • Named medical director / clinical leadership not disclosed
  • Corporate legal entity not disclosed
  • Governing law / arbitration venue not stated

Bottom line — Grade C

Best for: Shoppers who want women's-health GLP-1 with compounded or brand-name access.

Ranked #209 of 544 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Visit Eve ↗

Closest here

The rankings grading nearest Eve — the realistic shortlist.

NextMeds#212

NextMeds is a cash-pay telehealth platform offering compounded semaglutide and compounded tirzepatide on a flat monthly membership — one price bundling the medication (if prescribed), telehealth visits, a 1:1 care coach, and a licensed registered dietitian, with free shipping and no insurance.

Queen RX#213

Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo).

TOM Weight Loss#214

Solo-physician DTC telemedicine clinic in Texas + Utah operated by Dr. Tran Le, MD (ABOM-board-certified obesity medicine, ABPM-certified addiction + occupational medicine, NPI 1194212258).

Coivas#215

Coivas is an all-inclusive GLP-1 telehealth service operated by WellVi LLC (d/b/a Coivas) with prescriptions through Arora Health & Aesthetics, LLC.

Revel Health#216

Revel Health is a telehealth platform combining GLP-1 weight loss with longevity care — semaglutide and tirzepatide plus NAD+, sermorelin and peptide therapy — prescribed by board-certified physicians and compounded in USP 795/800-compliant facilities.

10rx#219

10rx is a nationwide GLP-1 telehealth program offering compounded weight-loss medication at low flat monthly rates: semaglutide at $99.67/month and tirzepatide at $149.67/month, with NAD+ and sermorelin also offered for energy and recovery.

The 18 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Eve's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Eve's site. Not medical advice; see our disclosure.

← Back to the scorecard